ArticleCancer research communications2026

Intratumoral Virus-Like Particles Containing a TLR9 Agonist Combined with Systemic αPD-1 Activate Tumor-Specific CD8+ T Cells.

Travis D Fischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.